Clinical trials: Progression of Non-small Cell Lung Cancer

NSCLC, Stage I, II, IIIA, IIIB, Surgery

Pronostic and Predictive Value of EMT in Localized Lung Cancer

• Unknown status
• Age: 18 to 100 years
• Observational study

The goal of the present research is to identify an "EMT signature", associated with long term disease-free survival after surgery in NSCLC.

Conditions

NSCLC, Stage I, II, IIIA, IIIB, Surgery, Progression, Epithelial Mesenchymal Transition

Trial name

TWISTlung (NCT03509779)

Where

France

Volunteers

1,000 people

Sponsor

European Georges Pompidou Hospital